NCT03514121 2024-11-22FPA150-001Five Prime Therapeutics, Inc.Phase EARLY_PHASE1 Terminated95 enrolled 36 charts
NCT02728830 2024-02-21A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic CancersDuke UniversityPhase EARLY_PHASE1 Completed39 enrolled 16 charts
NCT01979003 2022-02-24Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer InvasionUniversity of ArkansasPhase EARLY_PHASE1 Completed100 enrolled 6 charts
NCT01705288 2020-02-17Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot StudyMasonic Cancer Center, University of MinnesotaPhase EARLY_PHASE1 Completed103 enrolled 9 charts